US FDA Makes Misinformation Correction Easier For Pharma

 
• By Sarah Karlin-Smith
  
Emoticon showing ok sign
New draft guidance okays companies skirting some FDA promotion rules to respond to online misinformation. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Marketing & Advertising

More from Compliance